GSK plc (GLAXF)
OTCMKTS
· Delayed Price · Currency is USD
20.24
-0.27 (-1.29%)
Jun 6, 2025, 1:12 PM EDT
GSK plc Revenue
GSK plc had revenue of 7.52B GBP in the quarter ending March 31, 2025, with 2.08% growth. This brings the company's revenue in the last twelve months to 31.53B, up 2.57% year-over-year. In the year 2024, GSK plc had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
31.53B GBP
Revenue Growth
+2.57%
P/S Ratio
2.04
Revenue / Employee
459.41K GBP
Employees
68,629
Market Cap
82.94B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
GSK plc News
- 14 days ago - GSK shares break six-session winning streak - Seeking Alpha
- 15 days ago - GSK wins EU backing for multiple myeloma drug, Blenrep - Seeking Alpha
- 15 days ago - Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD) - Business Wire
- 15 days ago - GSK wins FDA label expansion for asthma therapy Nucala in COPD - Seeking Alpha
- 15 days ago - GSK's asthma drug Nucala wins FDA's approval to treat 'smoker's lung' - Reuters
- 17 days ago - Pharma stocks rally: Glaxo surges 7%, Torrent gains after Q4; Gland steady post mixed results - Business Upturn
- 19 days ago - GSK's Blood-Cancer Treatment Combinations Approved in Japan - WSJ
- 20 days ago - Notable healthcare headlines for the week: UnitedHealth, Novo Nordisk and GSK in focus - Seeking Alpha